milnacipran has been researched along with Tachycardia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Forero, G; Gommoll, C; Greenberg, WM; Mago, R | 1 |
| Forman, MB; Jackson, EK; Sutej, PG | 1 |
1 trial(s) available for milnacipran and Tachycardia
| Article | Year |
|---|---|
Safety and tolerability of levomilnacipran ER in major depressive disorder: results from an open-label, 48-week extension study.
Topics: Adult; Antidepressive Agents; Cyclopropanes; Delayed-Action Preparations; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Milnacipran; Tachycardia; Time Factors | 2013 |
1 other study(ies) available for milnacipran and Tachycardia
| Article | Year |
|---|---|
Hypertension, tachycardia, and reversible cardiomyopathy temporally associated with milnacipran use.
Topics: Adrenergic Uptake Inhibitors; Adult; Cardiomyopathies; Cardiovascular Agents; Catecholamines; Coronary Angiography; Cyclopropanes; Female; Humans; Hypertension; Magnetic Resonance Imaging; Milnacipran; Selective Serotonin Reuptake Inhibitors; Tachycardia; Time Factors; Treatment Outcome; Up-Regulation | 2011 |